LP
LIGAND PHARMACEUTICALS
LGND· Health Care· BiotechnologyS&P 600
Close · 10/09/2026
289.25
1D
+0.42%52-week range
161.82 – 326.63
Volume
1,46,600.00
Price history
LGND
11/08/2026 to 10/09/2026
O 285.00 H 291.26 L 283.04
1W+0.81%
1M+0.17%
3M+16.52%
6M+30.74%
1Y+74.87%
3Y+355.30%
5Y+231.81%
MAX+262.47%
Fundamentals
as of 10/09/2026- Market cap
- $5.77B
- Shares out
- 19.94M
- P/E (trailing)
- 29.24
- P/E (forward)
- 23.93
- EPS (trailing)
- 9.89
- Beta
- 0.98
- Profit margin
- 67.88%
- P/B
- 5.96
- Return on equity
- 20.38%
SEC financial statements
61 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- LGND
- Index
- SP600
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 4 buys · 0 sells · D: 4
- 29/05/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/03/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 15/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 05/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000